{"id":163,"date":"2026-11-05T13:01:31","date_gmt":"2026-11-05T02:01:31","guid":{"rendered":"https:\/\/pressuraneuro.com\/newsite\/?page_id=163"},"modified":"2026-11-20T11:37:56","modified_gmt":"2026-11-20T00:37:56","slug":"science","status":"publish","type":"page","link":"https:\/\/pressuraneuro.com\/newsite\/science\/","title":{"rendered":"Science"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; module_class=&#8221;pn-science-current-title&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; background_enable_color=&#8221;off&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; border_color_all=&#8221;gcid-6d5e15e2-bc98-4253-aa71-4c19bf47ea9f&#8221; border_width_bottom=&#8221;1px&#8221; border_color_bottom=&#8221;#000000&#8243; global_colors_info=&#8221;{%22gcid-6d5e15e2-bc98-4253-aa71-4c19bf47ea9f%22:%91%22background_color%22,%22border_color_all%22%93}&#8221;][et_pb_row _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; text_orientation=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>Science<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; module_class=&#8221;pn-science-current-intro&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;1320px&#8221; module_alignment=&#8221;center&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||0px||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;3_5,2_5&#8243; make_equal=&#8221;on&#8221; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;1320px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text disabled_on=&#8221;on|on|off&#8221; admin_label=&#8221;Moderate to Severe Traumatic Brain Injury.&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; text_orientation_tablet=&#8221;&#8221; text_orientation_phone=&#8221;center&#8221; text_orientation_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Moderate to Severe<br \/>Traumatic Brain Injury.<\/h2>\n<p>&nbsp;<\/p>\n<p>PresSura is targeting the control of intracranial pressure (ICP) to prevent injury caused by brain swelling. All preclinical and Phase 1 development has been completed and an international Phase 2A programme has completed patient enrolment. Success is expected to result in a paradigm shift in the treatment of elevated ICP.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/i-mean-science.png&#8221; alt=&#8221;Neural network scientific visualisation&#8221; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;80%&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row make_equal=&#8221;on&#8221; disabled_on=&#8221;off|off|on&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;1320px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/i-mean-science.png&#8221; alt=&#8221;Neural network scientific visualisation&#8221; disabled_on=&#8221;off|off|on&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;-80px||||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;0px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text disabled_on=&#8221;off|off|on&#8221; admin_label=&#8221;Moderate to Severe Traumatic Brain Injury.&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; text_orientation_tablet=&#8221;&#8221; text_orientation_phone=&#8221;center&#8221; text_orientation_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Moderate to Severe<br \/>Traumatic Brain Injury.<\/h2>\n<p>&nbsp;<\/p>\n<p>PresSura is targeting the control of intracranial pressure (ICP) to prevent injury caused by brain swelling. All preclinical and Phase 1 development has been completed and an international Phase 2A programme has completed patient enrolment. Success is expected to result in a paradigm shift in the treatment of elevated ICP.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; disabled_on=&#8221;off|on|on&#8221; module_class=&#8221;pn-science-current-benefits&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;1320px&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;0px||||false|false&#8221; border_color_all=&#8221;gcid-07b6f789-5cf9-4446-9411-719b1b66984a&#8221; border_width_bottom=&#8221;1px&#8221; border_color_bottom=&#8221;gcid-6d5e15e2-bc98-4253-aa71-4c19bf47ea9f&#8221; global_colors_info=&#8221;{%22gcid-6d5e15e2-bc98-4253-aa71-4c19bf47ea9f%22:%91%22border_color_bottom%22%93,%22gcid-07b6f789-5cf9-4446-9411-719b1b66984a%22:%91%22border_color_all%22%93}&#8221;][et_pb_row _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;1320px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/photo.png&#8221; alt=&#8221;Benefits&#8221; title_text=&#8221;photo&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; header_2_line_height=&#8221;2em&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;95%&#8221; width_last_edited=&#8221;on|phone&#8221; custom_margin=&#8221;25px||||false|false&#8221; text_orientation_tablet=&#8221;&#8221; text_orientation_phone=&#8221;center&#8221; text_orientation_last_edited=&#8221;on|phone&#8221; module_alignment_tablet=&#8221;&#8221; module_alignment_phone=&#8221;center&#8221; module_alignment_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Targeted Benefits.<\/h2>\n<p>A successful treatment would deliver significant improvements in functional independence and quality of life, helping people regain control over daily activities, cognitive function and physical abilities. By reducing the health burden of TBI, it would also lower the economic burden of ongoing medical support, therapies, neurological medications, compensating strategies and community reintegration.<\/p>\n<p>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/targeted-benefits.png&#8221; alt=&#8221;Targeted benefits&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; disabled_on=&#8221;on|off|off&#8221; module_class=&#8221;pn-science-current-benefits&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;1320px&#8221; module_alignment=&#8221;center&#8221; border_color_all=&#8221;gcid-07b6f789-5cf9-4446-9411-719b1b66984a&#8221; border_width_bottom=&#8221;1px&#8221; border_color_bottom=&#8221;gcid-6d5e15e2-bc98-4253-aa71-4c19bf47ea9f&#8221; global_colors_info=&#8221;{%22gcid-6d5e15e2-bc98-4253-aa71-4c19bf47ea9f%22:%91%22border_color_bottom%22%93,%22gcid-07b6f789-5cf9-4446-9411-719b1b66984a%22:%91%22border_color_all%22%93}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;1320px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/targeted-benefits.png&#8221; alt=&#8221;Targeted benefits&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/photo.png&#8221; alt=&#8221;Benefits&#8221; title_text=&#8221;photo&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; header_2_line_height=&#8221;2em&#8221; width=&#8221;80%&#8221; width_tablet=&#8221;80%&#8221; width_phone=&#8221;95%&#8221; width_last_edited=&#8221;on|phone&#8221; custom_margin=&#8221;25px||||false|false&#8221; text_orientation_tablet=&#8221;&#8221; text_orientation_phone=&#8221;center&#8221; text_orientation_last_edited=&#8221;on|phone&#8221; module_alignment_tablet=&#8221;&#8221; module_alignment_phone=&#8221;center&#8221; module_alignment_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Targeted Benefits.<\/h2>\n<p>A successful treatment would deliver significant improvements in functional independence and quality of life, helping people regain control over daily activities, cognitive function and physical abilities. By reducing the health burden of TBI, it would also lower the economic burden of ongoing medical support, therapies, neurological medications, compensating strategies and community reintegration.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; module_class=&#8221;pn-science-current-mode pn-about-section pn-about-details&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#ffffff&#8221; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_stops=&#8221;#ffffff 0%|#ffffff 23%|#e4edff 78%|#ffffff 100%&#8221; custom_margin=&#8221;||0px||false|false&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;1320px&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;0px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; header_2_text_align=&#8221;center&#8221; header_2_line_height=&#8221;2em&#8221; text_orientation=&#8221;center&#8221; max_width=&#8221;700px&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Mode of Action.<\/h2>\n<p> A traumatic brain injury triggers a vicious cycle of neurogenic inflammation, oedema and classical inflammation. EU-C-001 is designed to interrupt this cycle, allowing the brain to recover by stopping the process of oedema formation. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;on|off|off&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;1280px&#8221; custom_padding=&#8221;25px||90px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/Mode-of-Action-Diagram-1.png&#8221; alt=&#8221;Mode of action diagram&#8221; title_text=&#8221;Mode of Action Diagram&#8221; force_fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text disabled_on=&#8221;on|off|off&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; text_orientation=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Corrigan et al., 2016<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;1280px&#8221; custom_padding=&#8221;25px||90px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/Vicious-Cycle-Diagram.png&#8221; alt=&#8221;Mode of action diagram&#8221; title_text=&#8221;Vicious Cycle Diagram&#8221; align=&#8221;center&#8221; disabled_on=&#8221;off|on|on&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text disabled_on=&#8221;off|on|on&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"pn-cycle-points\">\n<div class=\"pn-cycle-point\">\n    <span class=\"pn-cycle-number\">1<\/span><\/p>\n<p>Proteins released as a consequence of brain injury.<\/p>\n<\/p><\/div>\n<div class=\"pn-cycle-point\">\n    <span class=\"pn-cycle-number\">2<\/span><\/p>\n<p>Trigger development of neurogenic inflammation and oedema.<\/p>\n<\/p><\/div>\n<div class=\"pn-cycle-point\">\n    <span class=\"pn-cycle-number\">3<\/span><\/p>\n<p>Leading to \u201cClassical Inflammation\u201d releasing histamine<\/p>\n<\/p><\/div>\n<div class=\"pn-cycle-point\">\n    <span class=\"pn-cycle-number\">4<\/span><\/p>\n<p>Histamine triggers further protein release and a vicious cycle<\/p>\n<\/p><\/div>\n<p class=\"pn-cycle-reference\">Corrigan et al., 2016<\/p>\n<\/div>\n<p>[\/et_pb_text][et_pb_text disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.27.9&#8243; _module_preset=&#8221;default&#8221; text_orientation=&#8221;center&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Corrigan et al., 2016<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row module_class=&#8221;pn-about-decoration&#8221; _builder_version=&#8221;4.27.9&#8243; positioning=&#8221;absolute&#8221; position_origin_a=&#8221;bottom_right&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.9&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/pressuraneuro.com\/newsite\/wp-content\/uploads\/2026\/11\/pres-sura-image.png&#8221; align=&#8221;right&#8221; module_class=&#8221;pn-corner-graphic pn-corner-right&#8221; _builder_version=&#8221;4.27.9&#8243; width=&#8221;480px&#8221; max_width=&#8221;480px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ScienceModerate to SevereTraumatic Brain Injury. &nbsp; PresSura is targeting the control of intracranial pressure (ICP) to prevent injury caused by brain swelling. All preclinical and Phase 1 development has been completed and an international Phase 2A programme has completed patient enrolment. Success is expected to result in a paradigm shift in the treatment of elevated [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-163","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pressuraneuro.com\/newsite\/wp-json\/wp\/v2\/pages\/163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressuraneuro.com\/newsite\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pressuraneuro.com\/newsite\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pressuraneuro.com\/newsite\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pressuraneuro.com\/newsite\/wp-json\/wp\/v2\/comments?post=163"}],"version-history":[{"count":68,"href":"https:\/\/pressuraneuro.com\/newsite\/wp-json\/wp\/v2\/pages\/163\/revisions"}],"predecessor-version":[{"id":500,"href":"https:\/\/pressuraneuro.com\/newsite\/wp-json\/wp\/v2\/pages\/163\/revisions\/500"}],"wp:attachment":[{"href":"https:\/\/pressuraneuro.com\/newsite\/wp-json\/wp\/v2\/media?parent=163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}